Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
7.88
+0.05 (0.64%)
At close: Jun 27, 2025, 4:00 PM
7.77
-0.11 (-1.40%)
After-hours: Jun 27, 2025, 7:56 PM EDT
Nutriband Employees
Nutriband had 13 employees as of January 31, 2022. The number of employees increased by 8 or 160.00% compared to the previous year.
Employees
13
Change (1Y)
8
Growth (1Y)
160.00%
Revenue / Employee
$184,495
Profits / Employee
-$767,185
Market Cap
87.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NTRB News
- 19 days ago - Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology - GlobeNewsWire
- 2 months ago - Nutriband CEO Publishes Letter to Shareholders - GlobeNewsWire
- 2 months ago - Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewsWire
- 3 months ago - UPDATE – Nutriband Signs Associate Partnership with Charlotte FC - GlobeNewsWire
- 3 months ago - Nutriband Signs Partnership Agreement with Charlotte FC - GlobeNewsWire
- 4 months ago - Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. - GlobeNewsWire
- 4 months ago - Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch - GlobeNewsWire
- 5 months ago - Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™ - GlobeNewsWire